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of high-intensity transient signals and
avoids interobserver variability, whereas
discrimination between solid and gaseous
microemboli may have important patho-
physiologic, therapeutic, and prognostic
implications.
The limitation of undercounting show-
ers of microemboli (such as during removal
of crossclamps and side clamps) was, in
fact, discussed in our article. Although Mo-
tallebzadeh and Jahangiri suggest that this
limitation may be responsible for a large
difference in embolic count relative to pre-
vious reports, a review of the literature
reveals that there is already wide variability
among different studies (Table 1) because
of differences in detection characteristics
among various transcranial Doppler sys-
tems. Furthermore, the phenomenon of
“undercounting” may actually serve to un-
derestimate the benefits of off-pump sur-
gery with a “no touch” aortic technique,
where such showers are not seen.
At the time of our study, it was not our
routine practice in Oxford to use arterial
line filters. We now do so, although evi-
dence for this is still not compelling. Oth-
ers have reported an abundance of micro-
emboli during cardiopulmonary bypass
despite the use of 40-m arterial filtration,1
and leukocyte-depleting arterial line filters
have reportedly failed to improve neuro-
cognitive outcome.2 On the other hand, the
use of a cell saver in place of cardiotomy
suction can potentially reduce the number
of lipid microemboli. Although a combina-
tion of these techniques is likely to reduce
microembolization during cardiopulmo-
nary bypass, it is still unlikely to reach the
levels seen in off-pump surgery with a “no
touch” aortic technique.
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The answer is an intra-aortic
balloon pump
To the Editor:
We have presented an article1 in the Jour-
nal with a case of wrong anastomosis of the
left internal thoracic artery (LITA) with the
cardiac vein that could not be detected with
transit flow measurement. The LITA graft
anastomosed with the cardiac vein demon-
strated biphasic and diastolic-dominant
flow, forming a trapezoid-shaped wave-
form, which was quite similar to the flow of
the patent LITA graft to the left coronary
artery.
Readers may not be able to understand
why the arteriovenous flow pattern was
similar to the arterioarterial flow pattern in
this patient, because we did not discuss the
mechanism that caused this similarity. In
addition, readers may think that this simi-
larity in flow pattern between the arterio-
venous graft and the arterioarterial graft
supports the idea of selective arterialization
of the coronary venous system for patients
with severe diffuse coronary artery dis-
ease.2-4 More recently, this idea has been
expanded to the concept of percutaneous in
situ coronary venous arterialization.5
The answer for this is the use of the
intra-aortic balloon pump (IABP) in our
patient. We have been applying prophylac-
tic and preincision IABP aggressively to
patients undergoing coronary artery bypass
grafting. The IABP-induced diastolic flow
augmentation of the incorrect LITA graft
may result in the trapezoid-shaped wave-
form in transit flow measurement. Unfor-
tunately, we did not record the waveform
of the graft without IABP counterpulsation
in this patient. We need further investiga-
tion of the flow pattern of the graft to the
TABLE 1. Variation in microembolic
counts among different studies
Study On-pump
Off-
pump
Abu-Omar et al, 20043 275 40
Motallebzadeh et al, 20044 2016 16
Scarborough et al, 20035 372 47
Lund et al, 20036 90 16
Lee et al, 20037 575 16
Mullges et al, 20038 175, 413* —
Bowles et al, 20019 1766 27
Fearn et al, 20011 136 —
Diegeler et al, 200010 395 11
Borger et al, 199911 152, 249† —
Taylor et al, 199912 207 —
*Different cannulation techniques. †Difference
in cannulation site.
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coronary vein without IABP counterpulsa-
tion.
Our article1 does not support the idea of
coronary venous arterialization. We did not
ligate the cardiac vein distally to isolate the
arterialized venous system from the rest of
the venous anatomy and to prevent steal
through the coronary sinus to the right
atrium, as is performed in surgical or per-
cutaneous arterialization of the coronary
venous system. However, even in the pres-
ence of the steal to the right atrium, the
flow pattern of the arteriovenous graft we
demonstrated may give the readers some
suggestions regarding the physiology of the
arterialized coronary venous system.
To be exact, the main finding of our
article1 is that it is impossible to detect
incorrect grafting of the LITA to the coro-
nary vein by flow waveform analysis with
the transit time flow measurement under
IABP counterpulsation.
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Difficulty of early diagnosis in
patients with solitary pulmonary
nodule
To the Editor:
We would like to express our opinion
about the article by Crestanello and as-
sociates.1 First, we congratulate them for
the well-performed study contributing to
the early diagnosis of lung cancer. Be-
cause an early diagnosis is likely to lead
to better survival, it is necessary to find a
useful, easy, low-cost method to obtain
better survival in patients with non–small
cell lung cancer. But the results of this
study seem to indicate that low-dose
computed tomography (CT) screening is
not the gold standard to obtain an early
diagnosis. Low-dose CT screening in a
well-selected group of patients detects a
large number of indeterminate pulmonary
nodules, but the diagnosis is not always
made in the early stage; 7 patients
(14.5%) had advanced lung cancer in
stage IIIA or greater. These patients had
a late diagnosis, despite an excellent
treatment algorithm and a retrospective
analysis of previous thorax CT. The per-
centage of patients with advanced lung
cancer is very high for a well-selected
group of patients, how is relatively high
(39%) the percentage of benign nodules
submitted to surgical operation.2 Discus-
sants emphasized that the main problem
remains in detecting nodules less than 1
cm in diameter, whereas fortunately no
discussion is necessary on the detection
of nodules larger than 2 cm.
What is meant by the authors’ state-
ment, “morphologic appearance worrisome
for cancer”?
Did the authors consider ground-glass
opacity or other CT pattern? In their study,
did the authors investigate the presence of
ground-glass opacity3 in nodules less than
1 cm in diameter? Some recent studies
have established a correlation between this
CT pattern and the possibility of a malig-
nant pulmonary nodule. If they studied this
pattern, was the correlation observed in 37
nodules less than 1 cm in diameter in the
patients enrolled in their study?
Last, what do the authors think about a
computer-aided diagnosis and serial CT
scan? These 2 methods have been proposed
to distinguish between benign and malig-
nant nodules.4,5 The computer-aided pro-
gram can predict the histology of solitary
pulmonary nodules by means of a simple
chest x-ray film, whereas the serial CT scan
algorithm enables volumetric modeling and
may permit accurate assessment of dou-
bling time over a relatively short period (20
days).
In conclusion, we believe that low-dose
CT alone is not adequate to screen for
solitary pulmonary nodules because it is
possible to miss an early diagnosis and
difficult to differentiate between malignant
and benign nodules.
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Reply to the Editor:
We appreciate Sortini and colleagues’
comments concerning our report regarding
surgical intervention in patients enrolled in
a computed tomography (CT) screening
trial. The radiographic finding in nodules
that we considered worrisome for cancer
include spiculation, noncalcification, diam-
eter greater than 7 mm, and enlargement on
serial examination.
The question about ground-glass opac-
ities observed on CT is important. Our cur-
rent policy is to carefully observe ground-
glass opacities that are less than 7.0 mm in
diameter. If they enlarge, we would either
perform a percutaneous needle biopsy or
thoracoscopic wedge resection of the nod-
ule to establish a histologic diagnosis.
Our report included 16 patients in the
surgical group with ground-glass opacities.
Six of these patients had nodules that were
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